164 related articles for article (PubMed ID: 36240289)
41. Transformed diffuse large B-cell lymphomas with gains of the discontinuous 12q12-14 amplicon display concurrent deregulation of CDK2, CDK4 and GADD153 genes.
Al-Assar O; Rees-Unwin KS; Menasce LP; Hough RE; Goepel JR; Hammond DW; Hancock BW
Br J Haematol; 2006 Jun; 133(6):612-21. PubMed ID: 16704435
[TBL] [Abstract][Full Text] [Related]
42. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
[TBL] [Abstract][Full Text] [Related]
43. Primary mediastinal large B-cell lymphoma: transcriptional regulation by miR-92a through FOXP1 targeting.
Romero M; Gapihan G; Castro-Vega LJ; Acevedo A; Wang L; Li ZW; El Bouchtaoui M; Di Benedetto M; Ratajczak P; Feugeas JP; Thieblemont C; Saavedra C; Janin A
Oncotarget; 2017 Mar; 8(10):16243-16258. PubMed ID: 27806315
[TBL] [Abstract][Full Text] [Related]
44. The relationship of REL proto-oncogene to pathobiology and chemoresistance in follicular and transformed follicular lymphoma.
Hu X; Baytak E; Li J; Akman B; Okay K; Hu G; Scuto A; Zhang W; Küçük C
Leuk Res; 2017 Mar; 54():30-38. PubMed ID: 28095352
[TBL] [Abstract][Full Text] [Related]
45. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
[TBL] [Abstract][Full Text] [Related]
46. Amplification of 2p as a genomic marker for transformation in lymphoma.
Kwiecinska A; Ichimura K; Berglund M; Dinets A; Sulaiman L; Collins VP; Larsson C; Porwit A; Lagercrantz SB
Genes Chromosomes Cancer; 2014 Sep; 53(9):750-68. PubMed ID: 24832791
[TBL] [Abstract][Full Text] [Related]
47. [The Importance of MicroRNA Deregulation in the Molecular Pathogenesis and Histological Transformation of Follicular Lymphoma].
Musilová K; Deván J; Zlámalíková L; Křen L; Móciková H; Procházka V; Mayer J; Trněný M; Janíková A; Mráz M
Klin Onkol; 2017; 30(Supplementum1):163-165. PubMed ID: 28471196
[TBL] [Abstract][Full Text] [Related]
48. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping.
Gong Y; Caraway N; Gu J; Zaidi T; Fernandez R; Sun X; Huh YO; Katz RL
Cancer; 2003 Dec; 99(6):385-93. PubMed ID: 14681948
[TBL] [Abstract][Full Text] [Related]
50. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
[TBL] [Abstract][Full Text] [Related]
51. Genetics of follicular lymphoma transformation.
Pasqualucci L; Khiabanian H; Fangazio M; Vasishtha M; Messina M; Holmes AB; Ouillette P; Trifonov V; Rossi D; Tabbò F; Ponzoni M; Chadburn A; Murty VV; Bhagat G; Gaidano G; Inghirami G; Malek SN; Rabadan R; Dalla-Favera R
Cell Rep; 2014 Jan; 6(1):130-40. PubMed ID: 24388756
[TBL] [Abstract][Full Text] [Related]
52. Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
Chaudhary S; Brown N; Song JY; Yang L; Skrabek P; Nasr MR; Wong JT; Bedell V; Murata-Collins J; Kochan L; Li J; Zhang W; Chan WC; Weisenburger DD; Perry AM
Hum Pathol; 2021 Aug; 114():19-27. PubMed ID: 33964277
[TBL] [Abstract][Full Text] [Related]
53. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
54. [Genetic evolution of in situ follicular neoplasia to t(14;18)-positive aggressive B-cell lymphoma].
Vogelsberg A; Steinhilber J; Mankel B; Federmann B; Schmidt J; Montes-Mojarro IA; Hüttl K; Rodriguez-Pinilla M; Baskaran P; Nahnsen S; Piris MA; Ott G; Quintanilla-Martinez L; Bonzheim I; Fend F
Pathologe; 2021 Dec; 42(Suppl 2):122-128. PubMed ID: 34671837
[TBL] [Abstract][Full Text] [Related]
55. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
Karube K; Enjuanes A; Dlouhy I; Jares P; Martin-Garcia D; Nadeu F; Ordóñez GR; Rovira J; Clot G; Royo C; Navarro A; Gonzalez-Farre B; Vaghefi A; Castellano G; Rubio-Perez C; Tamborero D; Briones J; Salar A; Sancho JM; Mercadal S; Gonzalez-Barca E; Escoda L; Miyoshi H; Ohshima K; Miyawaki K; Kato K; Akashi K; Mozos A; Colomo L; Alcoceba M; Valera A; Carrió A; Costa D; Lopez-Bigas N; Schmitz R; Staudt LM; Salaverria I; López-Guillermo A; Campo E
Leukemia; 2018 Mar; 32(3):675-684. PubMed ID: 28804123
[TBL] [Abstract][Full Text] [Related]
56. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
[TBL] [Abstract][Full Text] [Related]
57. Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma.
Lawrie CH; Chi J; Taylor S; Tramonti D; Ballabio E; Palazzo S; Saunders NJ; Pezzella F; Boultwood J; Wainscoat JS; Hatton CS
J Cell Mol Med; 2009 Jul; 13(7):1248-60. PubMed ID: 19413891
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.
Bouska A; McKeithan TW; Deffenbacher KE; Lachel C; Wright GW; Iqbal J; Smith LM; Zhang W; Kucuk C; Rinaldi A; Bertoni F; Fitzgibbon J; Fu K; Weisenburger DD; Greiner TC; Dave BJ; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Staudt LM; Chan WC
Blood; 2014 Mar; 123(11):1681-90. PubMed ID: 24037725
[TBL] [Abstract][Full Text] [Related]
59. Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Bouska A; Zhang W; Gong Q; Iqbal J; Scuto A; Vose J; Ludvigsen M; Fu K; Weisenburger DD; Greiner TC; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Delabie J; Jaffe ES; Braziel RM; Connors JM; Wu CI; Staudt LM; D'Amore F; McKeithan TW; Chan WC
Leukemia; 2017 Jan; 31(1):83-91. PubMed ID: 27389057
[TBL] [Abstract][Full Text] [Related]
60. The utility of CD83, fascin and CD23 in the differential diagnosis of primary mediastinal large B-cell lymphoma versus classic Hodgkin lymphoma.
Aladily TN; Mansour A; Alsughayer A; Sughayer M; Medeiros LJ
Ann Diagn Pathol; 2019 Jun; 40():72-76. PubMed ID: 31075666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]